Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

M5-MCC: TB and comorbidity

  1. Home
  2. M5-MCC: TB and comorbidity
  • MCC: TB and HIV

    • National TB-HIV Collaborative Framework
    • Intensified TB Case Finding [ICF] in HIV testing Settings
    • HIV testing of individuals with presumed or confirmed TB
    • ART For TB-HIV Patients
    • Immune Reconstitution Inflammatory Syndrome [IRIS]
    • Co-trimoxazole prophylactic therapy in persons with HIV and TB coinfection
    • Isoniazid Preventive Therapy [IPT] in People Living with HIV [PLHIV]
    • Linkage to TB-HIV services in the private sector
    • Prevention of TB in facilities caring for HIV-infected persons
  • MCC: TB and Diabetes

    • TB and Diabetes comorbidity
    • Diabetes among people with TB
  • MCC: TB and malnourishment

    • Malnutrition among people with TB
    • Nutritional Support/ PMTBMBA
    • Nutritional Counselling
  • MCC: TB and Substance Abuse

    • Alcoholism among people with TB
    • Tobacco use among people with TB
  • MCC: TB and other comorbid conditions

    • TB Co-morbidities & Special Situations
    • Silicosis in people with TB
    • Cancer in People with TB
    • TB in Pregnant and Lactating Women
    • DR-TB Treatment in Pregnancy: Recommendation for the Use of Contraception​
    • COVID-19 in TB patients
  • MCC: Monitoring the comorbidities

    • Comorbidity Register
    • NTEP Performance Indicator - Percentage of TB Notified Patients with Known HIV Status
    • Ni-kshay HIV Status Report
Cover

M5-MCC: TB and comorbidity

User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International